India, Aug. 19 -- On Wednesday, XtalPi Holdings Ltd. (2228.HK), a healthcare research platform company, reported a slip to loss in the first half of 2026, compared to profit in the prior year, due to higher expenses.
Loss attributable to the equity holders of the company was RMB 251.90 million or RMB 6 cents per share, compared to profit of RMB 82.80 million or RMB 2 cents per share in the previous year.
Adjusted net loss for the first half was RMB 105.51 million, compared to profit of RMB 141.63 million in the same half a year ago.Research and development expenses went up to RMB 367.84 million from RMB 221.53 million in the prior year.
General and administrative expenses widened to RMB 212.14 million from RMB 200.33 million a year ago....